Home » Oxford BioMedica, Viragen, the Roslin Institute Achieve Milestone
Oxford BioMedica, Viragen, the Roslin Institute Achieve Milestone
Oxford BioMedica, the leading gene therapy company, Viragen, Inc. and the Roslin Institute (Scotland) announced a breakthrough in their collaborative project to develop Avian Transgenic Biomanufacturing. For the first time, the collaboration has produced a potentially therapeutic protein selectively in the whites of eggs laid by a transgenic hen. This technology is expected to offer a low cost manufacturing alternative for the production of many protein drugs, with additional potential advantages in the quality of the products.
()a href="http://www.bioportfolio.com/news/oxford_biomedica_51.htm" target="_blank">BioPortfolio
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
07May
-
14May
-
30May